A Comparison of Slow Trasicor (Oxprenolol 160 mg) and Trasidrex (Oxprenolol 160 mg and Cyclopenthiazide 0.25 mg) in the Treatment of Hypertension in General Practice
Restricted accessResearch articleFirst published online September, 1981
A Comparison of Slow Trasicor (Oxprenolol 160 mg) and Trasidrex (Oxprenolol 160 mg and Cyclopenthiazide 0.25 mg) in the Treatment of Hypertension in General Practice
A crossover study was carried out in general practice to compare Slow Trasicor and Trasidrex (a fixed combination of Slow Trasicor 160 mg and Navidrex 0.25 mg) in the treatment of newly diagnosed hypertensive patients. Trasidrex produced a significantly lower systolic and diastolic pressure, but there were no obvious differences in the incidence of side-effects between the two treatments.
Get full access to this article
View all access options for this article.
References
1.
BulpittC JDolleryC T (1973) British Medical Journal3, 485.
2.
WinerB J (1971) Statistical Principles in Experimental Design. McGraw-Hill.
